Catalyst Wire Dossier Catalyst Wire Dossier

BYSTOLIC

nebivolol hydrochloride · Allergan, Inc.
Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for BYSTOLIC, covering 2007-12-17 to 2023-06-16. Get the full timeline:

Most recent: FDA Approved: BYSTOLIC — Supplemental Application (Allergan, Inc.)

See pricing